Page last updated: 2024-08-24

cephalosporin c and oseltamivir

cephalosporin c has been researched along with oseltamivir in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	3 (100.00)	2.80

Authors

Authors	Studies
Amaro, R; Bassetti, M; Cilloniz, C; Giacobbe, DR; Graziano, E; Russo, A; Soriano, A; Torres, A; Vena, A	1
Abd El Ghafar, MS; Abd-Elsalam, S; Abdo, EF; Ahmed, OA; Alboraie, M; Esmail, ES; Khalaf, M; Medhat, MA; Serangawy, GN; Soliman, S	1
Alsultan, M; Ishaqui, AA; Khan, AH; Khan, I; Syed Sulaiman, SA	1

Trials

1 trial(s) available for cephalosporin c and oseltamivir

Article	Year
RETRACTED: Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study. The American journal of tropical medicine and hygiene, 2020, Volume: 103, Issue:4 Topics: Acetaminophen; Adult; Antiviral Agents; Betacoronavirus; Cephalosporins; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Repositioning; Egypt; Female; Humans; Hydrocortisone; Hydroxychloroquine; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Time Factors; Treatment Outcome	2020

Article

Year

RETRACTED: Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study.

The American journal of tropical medicine and hygiene, 2020, Volume: 103, Issue:4

Topics: Acetaminophen; Adult; Antiviral Agents; Betacoronavirus; Cephalosporins; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Repositioning; Egypt; Female; Humans; Hydrocortisone; Hydroxychloroquine; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Time Factors; Treatment Outcome

2020

Other Studies

2 other study(ies) available for cephalosporin c and oseltamivir

Article	Year
Ceftaroline for severe community-acquired pneumonia: A real-world two-centre experience in Italy and Spain. International journal of antimicrobial agents, 2020, Volume: 55, Issue:4 Topics: Aged; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Female; Humans; Italy; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oseltamivir; Pneumococcal Infections; Pneumonia; Retrospective Studies; Spain; Staphylococcal Infections; Streptococcus pneumoniae	2020
Assessment of Antiviral combination therapy with Cephalosporin antibiotic for prevention of severe Influenza-A (H1N1)pdm09 infection associated secondary bacterial infection and other complications. Pakistan journal of pharmaceutical sciences, 2020, Volume: 33, Issue:4(Suppleme Topics: Antiviral Agents; Bacterial Infections; Cephalosporins; Cohort Studies; Coinfection; Drug Therapy, Combination; Female; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir	2020

Article

Year

Ceftaroline for severe community-acquired pneumonia: A real-world two-centre experience in Italy and Spain.

International journal of antimicrobial agents, 2020, Volume: 55, Issue:4

Topics: Aged; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Female; Humans; Italy; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oseltamivir; Pneumococcal Infections; Pneumonia; Retrospective Studies; Spain; Staphylococcal Infections; Streptococcus pneumoniae

2020

Assessment of Antiviral combination therapy with Cephalosporin antibiotic for prevention of severe Influenza-A (H1N1)pdm09 infection associated secondary bacterial infection and other complications.

Pakistan journal of pharmaceutical sciences, 2020, Volume: 33, Issue:4(Suppleme

Topics: Antiviral Agents; Bacterial Infections; Cephalosporins; Cohort Studies; Coinfection; Drug Therapy, Combination; Female; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir

2020